AstraZeneca is a global innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
Through long-term strategic investments and a commitment to develop a strong business presence in the country, AstraZeneca has established itself as the largest multinational pharmaceutical group operating in China today.
With its business operations expanding rapidly, AstraZeneca faced the challenge of addressing the increased demands placed on its network infrastructure in China. Since 2003, Logicalis has been working with AstraZeneca to manage and optimise its network to keep up with the company’s growing needs.
Besides tapping on Logicalis’ expertise to support over 5,000 staff in 20 offices located across China, AstraZeneca also engaged Logicalis to carry out the implementation of critical network deployment in several locations. Major milestones reached over the past decade included a network refresh for AstraZeneca to make a successful transition to a fully IP-based MPLS infrastructure.
Through Logicalis Managed Services, AstraZeneca was able to continuously modernise its network infrastructure to meet the evolving requirements of its employees. The technical expertise and strong quality of support services provided by Logicalis made a critical difference in improving operational efficiency.
Logicalis also played a pivotal role in delivering highly versatile network solutions to facilitate wireless deployment and network optimisation across AstraZeneca’s new sites. The technology implementation was primarily based on the wireless networking solutions from Cisco, which are seamlessly integrated with the existing network infrastructure and IT systems deployed at AstraZeneca’s other offices located in China.
Following the implementation, AstraZeneca was able to reap significant improvements through the simplified network management across its China operations. An immediate benefit is the reduced operational burden placed on its network administrators, who were able to save up to an estimated 30 percent of their time each year—freeing up their time to focus on their core responsibilities and other strategic business initiatives.
The solutions provided by Logicalis were designed to bring enhanced network visibility, and helped reduce the need for additional manpower to manage the increased network demands. The ongoing support from Logicalis Managed Services further provides AstraZeneca the scalability to respond quickly to current and future network demands of its fast expanding operations.
“Logicalis is able to provide a full suite of services with superior process control, considerably improving our user satisfaction,” commented Xue Qidong, AsiaPac Architecture & Tower Service Lead, IT, AstraZeneca. "Enhanced productivity and optimised user experience are fundamental to our business. Logicalis is always able to deliver highly tailored solutions to meet these needs, and we are satisfied with the professional services provided by Logicalis’ highly knowledgeable local team.”
Backed by its global presence and wide-ranging technical expertise, Logicalis has established a longstanding cooperation with AstraZeneca.
Logicalis is able to support AstraZeneca by gaining a thorough understanding of its business objectives—in order to deliver the most effective technologies and support services to address their specific needs.
Logicalis Managed Services also enabled AstraZeneca to better manage and scale its IT investments, as well as significantly improve visibility into the performance of its network infrastructure.